Trials / Completed
CompletedNCT01087424
Mini-CHOP and Rituximab in Patients Aged Over 80 Years
Phase II Study of Mini-CHOP Plus Rituximab in Non Previously Treated Patients Aged Over 80 Years With CD 20+ Diffuse Large B-Cell Lymphoma
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 150 (actual)
- Sponsor
- Lymphoma Study Association · Academic / Other
- Sex
- All
- Age
- 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to evaluate efficacy and safety of R-miniCHOP for elderly patients with diffuse large B-Cell lymphoma (DLBC) Lymphoma aged over 80 years by measuring the overall survival.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | R mini CHOP | Prednisone 40 mg/m2 D1 D2 D3 D4 D5 Rituximab 375 mg/m2 D1 Doxorubicine 25 mg/m2 D1 Cyclophosphamide 400 mg/m2 D1 Vincristine 1 mg/m2 D1 |
Timeline
- Start date
- 2006-04-01
- Primary completion
- 2010-06-01
- Completion
- 2010-06-01
- First posted
- 2010-03-16
- Last updated
- 2019-08-26
Source: ClinicalTrials.gov record NCT01087424. Inclusion in this directory is not an endorsement.